BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 38576048)

  • 1. JMJD3 as an epigenetic regulator in development and disease.
    Burchfield JS; Li Q; Wang HY; Wang RF
    Int J Biochem Cell Biol; 2015 Oct; 67():148-57. PubMed ID: 26193001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer.
    Chen D; Cai B; Zhu Y; Ma Y; Yu X; Xiong J; Shen J; Tie W; Zhang Y; Guo F
    Clin Epigenetics; 2024 Apr; 16(1):51. PubMed ID: 38576048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and significance of histone H3K27 demethylases in renal cell carcinoma.
    Shen Y; Guo X; Wang Y; Qiu W; Chang Y; Zhang A; Duan X
    BMC Cancer; 2012 Oct; 12():470. PubMed ID: 23057811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EZH2, JMJD3, and UTX epigenetically regulate hepatic plasticity inducing retro-differentiation and proliferation of liver cells.
    Pediconi N; Salerno D; Lupacchini L; Angrisani A; Peruzzi G; De Smaele E; Levrero M; Belloni L
    Cell Death Dis; 2019 Jul; 10(7):518. PubMed ID: 31285428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases.
    Hong S; Cho YW; Yu LR; Yu H; Veenstra TD; Ge K
    Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18439-44. PubMed ID: 18003914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different expression patterns of histone H3K27 demethylases in renal cell carcinoma and bladder cancer.
    Hong Z; Li H; Li L; Wang W; Xu T
    Cancer Biomark; 2017; 18(2):125-131. PubMed ID: 27983522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the role of Jmjd3 and Utx in axial skeletal formation in mice.
    Naruse C; Shibata S; Tamura M; Kawaguchi T; Abe K; Sugihara K; Kato T; Nishiuchi T; Wakana S; Ikawa M; Asano M
    FASEB J; 2017 Jun; 31(6):2252-2266. PubMed ID: 28188179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSK-J4: An H3K27 histone demethylase inhibitor, as a potential anti-cancer agent.
    Dalpatraj N; Naik A; Thakur N
    Int J Cancer; 2023 Sep; 153(6):1130-1138. PubMed ID: 37165737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in epigenetic modifications and cervical cancer research.
    Liu H; Ma H; Li Y; Zhao H
    Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188894. PubMed ID: 37011697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selenium nanoparticles modulate histone methylation via lysine methyltransferase activity and S-adenosylhomocysteine depletion.
    Toubhans B; Alkafri N; Quintela M; James DW; Bissardon C; Gazze S; Knodel F; Proux O; Gourlan AT; Rathert P; Bohic S; Gonzalez D; Francis LW; Charlet L; Conlan RS
    Redox Biol; 2023 May; 61():102641. PubMed ID: 36842241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H3K18 lactylation marks tissue-specific active enhancers.
    Galle E; Wong CW; Ghosh A; Desgeorges T; Melrose K; Hinte LC; Castellano-Castillo D; Engl M; de Sousa JA; Ruiz-Ojeda FJ; De Bock K; Ruiz JR; von Meyenn F
    Genome Biol; 2022 Oct; 23(1):207. PubMed ID: 36192798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium selenite inhibits proliferation and metastasis through ROS-mediated NF-κB signaling in renal cell carcinoma.
    Liu X; Jiang M; Pang C; Wang J; Hu L
    BMC Cancer; 2022 Aug; 22(1):870. PubMed ID: 35945549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of inhibiting histone 3 lysine 27 demethylases: a review of the literature.
    Abu-Hanna J; Patel JA; Anastasakis E; Cohen R; Clapp LH; Loizidou M; Eddama MMR
    Clin Epigenetics; 2022 Aug; 14(1):98. PubMed ID: 35915507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Pan-Cancer Analysis Revealing the Dual Roles of Lysine (K)-Specific Demethylase 6B in Tumorigenesis and Immunity.
    Ding JT; Yu XT; He JH; Chen DZ; Guo F
    Front Genet; 2022; 13():912003. PubMed ID: 35783266
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.